Skip to main content
. 2023 Apr 11;2023:7563802. doi: 10.1155/2023/7563802

(a).

Experimental group (n = 18) Control group (n = 16)
Baseline Post p Baseline Post p
Walking speed 0.26 ± 0.19 0.54 ± 0.26 <0.001 0.31 ± 0.19 0.33 ± 0.18 0.040
Symmetry index 0.51 ± 0.19 0.84 ± 0.16 <0.001 0.59 ± 0.25 0.65 ± 0.20 0.021
Affected stride length 0.43 ± 0.22 0.71 ± 0.22 <0.001 0.52 ± 0.18 0.56 ± 0.18 0.010
Unaffected stride length 0.56 ± 0.20 0.67 ± 0.23 <0.001 0.47 ± 0.23 0.53 ± 0.19 0.393
Affected hip ROM 20.17 ± 7.51 29.57 ± 11.40 <0.001 22.69 ± 10.41 24.91 ± 10.17 0.010
Unaffected hip ROM 34.40 ± 8.15 36.26 ± 4.08 0.018 33.50 ± 13.50 36.30 ± 10.75 0.276
Affected knee flexion 31.95 ± 17.45 45.02 ± 13.67 0.001 28.94 ± 14.17 32.29 ± 14.74 0.068
Unaffected knee flexion 61.60 ± 15.25 60.05 ± 8.40 0.983 55.63 ± 12.23 55.93 ± 12.42 0.908
Affected ankle ROM 18.12 ± 6.13 24.38 ± 5.89 <0.001 18.84 ± 8.22 22.78 ± 10.07 0.023
Unaffected ankle ROM 24.38 ± 8.24 26.05 ± 15.60 0.054 23.67 ± 9.27 23.25 ± 9.05 0.793
FMA-LE 20.69 ± 6.76 23.88 ± 6.37 <0.001 17.31 ± 6.64 18.31 ± 6.42 0.008
FAC 3.00 ± 1.00 4.00 ± 1.00 0.001 3.00 ± 0.00 3.50 ± 1.00 0.002
6MWT 91.80 ± 141.00 139.15 ± 157.45 <0.001 117.70 ± 71.41 145.39 ± 73.42 0.002